Data mining of the public version of the FDA Adverse Event Reporting System
about
Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP ProjectAdverse Effects of Cholinesterase Inhibitors in Dementia, According to the Pharmacovigilance Databases of the United-States and CanadaFactors Affecting the Timing of Signal Detection of Adverse Drug ReactionsAssessment of the Risk of Suicide-Related Events Induced by Concomitant Use of Antidepressants in Cases of Smoking Cessation Treatment with Varenicline and Assessment of Latent Risk by the Use of VareniclineAssociation Patterns in Open Data to Explore Ciprofloxacin Adverse EventsComputational approaches for pharmacovigilance signal detection: toward integrated and semantically-enriched frameworksCommonality of drug-associated adverse events detected by 4 commonly used data mining algorithms.Association of statin use with sleep disturbances: data mining of a spontaneous reporting database and a prescription database.Lean Big Data integration in systems biology and systems pharmacology.Cardiovascular and pulmonary adverse events in patients treated with BCR-ABL inhibitors: Data from the FDA Adverse Event Reporting System.Big Data and Health Economics: Strengths, Weaknesses, Opportunities and Threats.Publisher’s Note:Abstraction for data integration:Fusing mammalian molecular, cellular and phenotype big datasets for better knowledge extraction.Inverse Association between Sodium Channel-Blocking Antiepileptic Drug Use and Cancer: Data Mining of Spontaneous Reporting and Claims Databases.Prevention of antipsychotic-induced hyperglycaemia by vitamin D: a data mining prediction followed by experimental exploration of the molecular mechanism.Data mining differential clinical outcomes associated with drug regimens using adverse event reporting data.Association between Benzodiazepine Use and Dementia: Data Mining of Different Medical Databases.HSP105 prevents depression-like behavior by increasing hippocampal brain-derived neurotrophic factor levels in miceAssociation between statin use and cancer: data mining of a spontaneous reporting database and a claims database.Evaluation of Dabigatran- and Warfarin-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database Stratified by AgeExploring adverse drug events at the class level.Using Literature-Based Discovery to Explain Adverse Drug Effects.Opportunities for Web-based Drug Repositioning: Searching for Potential Antihypertensive Agents with Hypotension Adverse EventsA survey of the FAERS database concerning the adverse event profiles of α1-adrenoreceptor blockers for lower urinary tract symptoms.Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database.A CTD-Pfizer collaboration: manual curation of 88,000 scientific articles text mined for drug-disease and drug-phenotype interactions.Discovering associations between adverse drug events using pattern structures and ontologies.Safety reporting through a comprehensive and pragmatic pharmcovigilance process for India and emerging markets: an industry perspective.The benefits of data mining.An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System.In silico Prediction of Drug-induced Liver Injury Based on Adverse Drug Reaction Reports.Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).Dipeptidyl Peptidase-4 Inhibitor-Associated Risk of Bleeding: An Evaluation of Reported Adverse Events.Safety of Perflutren Ultrasound Contrast Agents: A Disproportionality Analysis of the US FAERS Database.Development of an automated assessment tool for MedWatch reports in the FDA adverse event reporting system.A Quantitative Analysis of FDA Adverse Event Reports with Oral Bisphosphonates and Clostridium difficile.EUROmediCAT signal detection: a systematic method for identifying potential teratogenic medicationMelanoma associated with tumour necrosis factor-α inhibitors: a Research on Adverse Drug events And Reports (RADAR) project.The Risk of Glioblastoma with TNF Inhibitors.Cardiotoxicity in targeted therapy for breast cancer: A study of the FDA adverse event reporting system (FAERS).Association between an excess risk of acute kidney injury and concomitant use of ibuprofen and acetaminophen in children, retrospective analysis of a spontaneous reporting system.
P2860
Q28548499-F1A89E11-EF27-43E7-8BC9-991FFCAD4F2CQ28551402-38E0C3EE-0312-4835-969C-DAD83FF9A286Q28551405-DA4DC7FE-70D7-4244-8EC3-366CCE1F2497Q28554297-E43E72C4-ABCA-47D4-BDBA-243708FE23BFQ28602965-FA97949D-9847-4A5B-9322-D1485A8F339BQ28651547-E288F779-11E3-47CC-B98F-AACE5886DF90Q30790443-E7C57A5C-2A96-49AB-ADB2-0A51B02C49F2Q30803396-04DB9453-2E45-4B66-BEC1-88C9AC47ECA5Q30841748-DEEDC4B2-3D03-4865-A173-EB0270377E3FQ30884142-B647EA04-3F30-462E-B2F9-C7EF94AEB4B6Q30975567-2ABFC286-68F0-4618-8FA2-CC2C20A0DD92Q30976077-A936226B-E90A-463C-AE4C-493103D35DB5Q31040399-F3DCBF01-8946-43AA-B0F6-F96746A9FDCBQ31097538-B07870C2-B641-4A46-8E68-D164C274F2B3Q31114073-06AB20D8-A99A-4723-9575-705B95D4D5BAQ31144205-661C5BAA-2D94-4F82-B823-3B1BB3769D1DQ33746359-B725412D-F951-4C27-9D72-7278DD3F7678Q35069176-5496C3E2-A3C6-40F3-B230-F75E5AA19F20Q35475000-0EDF7CE1-CC9B-4F6F-9759-6AE02F8D5841Q35559500-AC5BA6F1-D703-4CB9-AB15-5223CDAA9C6AQ36056257-89C3BFCB-A544-4895-85F6-198166E50FD5Q36804419-02EB1EDD-3A89-4C36-8040-B81969E4F32CQ36909828-4BACA959-9DEC-453A-B2D0-7C4A111524F8Q37024628-384561CA-B8AA-410F-888E-04400B3AA813Q37348321-7C6D085E-098D-4DDC-B55B-E0B6DEABDD72Q38371804-8E521F07-C9C0-4031-A341-67B4D8E22B3EQ38570374-122904EF-7D72-49A1-99B1-659037413DE2Q38622261-5C14D41A-28B3-4AA5-8C10-C2DDBCE46430Q38673424-A31E7BE3-2FF5-4CE5-B536-A55EAC2C93CBQ38682276-BA5303C5-CFEA-48FD-9BAD-33B6EE3A262BQ38817615-B3CD6572-D1CB-40FD-8005-D16661B9123AQ38976138-24144A4B-538B-4FF3-9D3A-7255935BA92DQ39133567-12646A6F-2C98-4C68-B16E-E8844AA58EA5Q39216921-B46BD00D-0B88-4248-BCD3-5AEE14B4B8B0Q39434182-610313D1-325D-4EB2-9812-3E29AD86BAFDQ39648159-997FA58D-7DD0-419D-9168-1945131E8E76Q39845723-92EF0B85-9278-46A3-B4EA-AE619AA1CFAAQ39956333-1FBE0FAC-A7D0-4B71-BDA8-0E303AABF41DQ40218182-4BD868E1-26D5-4E54-AB72-6EF46CCFFF4CQ40220701-8B512EFD-E239-487E-B7F3-DC0F855C6248
P2860
Data mining of the public version of the FDA Adverse Event Reporting System
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Data mining of the public version of the FDA Adverse Event Reporting System
@ast
Data mining of the public version of the FDA Adverse Event Reporting System
@en
type
label
Data mining of the public version of the FDA Adverse Event Reporting System
@ast
Data mining of the public version of the FDA Adverse Event Reporting System
@en
prefLabel
Data mining of the public version of the FDA Adverse Event Reporting System
@ast
Data mining of the public version of the FDA Adverse Event Reporting System
@en
P2093
P2860
P356
P1476
Data mining of the public version of the FDA Adverse Event Reporting System
@en
P2093
Akiko Tamon
Kaori Kadoyama
Toshiyuki Sakaeda
Yasushi Okuno
P2860
P304
P356
10.7150/IJMS.6048
P407
P577
2013-04-25T00:00:00Z